SCHEMBL23925357

SCHEMBL23925357

C=CC(=O)NC(C)(C)C(=O)NC(COP(=O)([O-])[O-])C(=O)O.[Na+].[Na+]

nearest known ligand 0.32

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
GRN P28799 1/20 0.31
SORT1 Q99523 1/20 0.31
TGM2 P21980 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19951572 0.78 TGFBR1 (0.44) ALDH1A1CYP3A4CYP2C9CYP2C19TGM2
SCHEMBL25263724 0.74 ZDHHC20 (0.33) ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL30374615 0.73 ALDH1A1 (0.33) ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL19951581 0.71 NPSR1 (0.56) ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL19963651 0.70 CYP2C9 (0.33) ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL19951565 0.69 FOLH1 (0.50) ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL19963562 0.68 ALDH1A1 (0.31) ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL29867919 0.68 ALDH1A1 (0.50) ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL24334152 0.68 TSHR (0.37) ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL21117090 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227496-A1 FLOW-THROUGH PROCESSES AND DEVICES FOR PURIFYING A TARGET MOLECULE SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2023-07-20 US disclosed
EP-4136093-A1 FLOW-THROUGH PROCESSES AND DEVICES FOR PURIFYING A TARGET MOLECULE 3M Innovative Properties Company (US) 2023-02-22 EP disclosed
WO-2021209851-A1 FLOW-THROUGH PROCESSES AND DEVICES FOR PURIFYING A TARGET MOLECULE 3M INNOVATIVE PROPERTIES COMPANY (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227496-A1 FLOW-THROUGH PROCESSES AND DEVICES FOR PURIFYING A TARGET MOLECULE SHBG, SERPINA6, IDE ALDH1A1 3634/4885CYP3A4 1524/4885CYP2C9 2767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.